Blackstone Labs

EpiSmash

Serving

1 Tablet(s)

Per container

Form

tablet

DSLD

246865

Avoid-flaggedObjective label signals

Flagged excipients

1 avoid · 1 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

2 active ingredients

Ingredient	Amount	% DV
Acacia catechu extract Acacia	375 mg	—
5-Alpha Hydroxy Laxogenin 5-Alpha-Hydroxy Laxogenin	100 mg	—

Flagged excipients

2 flagged · authority citations

● AVOIDTitanium Dioxide
color
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
◐ CAUTIONFD&C Red #40
color
EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).
eur-lex.europa.eu →leginfo.legislature.ca.gov →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcrystalline Cellulose · Phosphatidylcholine · Hydroxypropyl-Beta-Cyclodextrin · Phytosterol · Stearic Acid · Magnesium Stearate · Starch · Silica